Coherus Oncology
CHRS
CHRS
124 hedge funds and large institutions have $72.6M invested in Coherus Oncology in 2025 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less capital invested
Capital invested by funds: $84.7M → $72.6M (-$12.1M)
24.28% less ownership
Funds ownership: 66.57% → 42.29% (-24%)
Holders
124
Holding in Top 10
1
Calls
$558K
Puts
$58K
Top Buyers
| 1 | +$962K | |
| 2 | +$696K | |
| 3 | +$682K | |
| 4 |
Jane Street
New York
|
+$573K |
| 5 |
Two Sigma Advisers
New York
|
+$430K |
Top Sellers
| 1 | -$3.46M | |
| 2 | -$1.48M | |
| 3 | -$483K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$481K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$426K |
